Back

IJPER · Lens · In vitro Anti-atherothrombosis Activity of Nigella sativa Oil, Phytol and their Combinations

PDF

Article · Volume 53, Issue 4 · pp. 670–674

In vitro Anti-atherothrombosis Activity of Nigella sativa Oil, Phytol and their Combinations

Muhammad Torequl Islam1,2, Shamim Molla3, Apu Kumar Das3, Farhana Zaman3, Md. Roich Khan3

  1. 1Department for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City-700000, VIETNAM.
  2. 2Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City-700000, VIETNAM.
  3. 3Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj (Dhaka)-8100, BANGLADESH.

Abstract

Background: Black seed oil and Phytol (PHY) are evident for their promising biological effects in various test systems.Aim: This study evaluates anti-atherothrombosis activity of Nigella sativa oil (NSO) and Phytol (PHY).Materials and Methods: The clotlysis activity of the NSO and/or PHY has been investigated by taking Streptokinase (SK) as a standard clotlysis drug.Results: The results suggest that the NSO and PHY exhibited a concentration-dependent clotlysis activity in human clotted blood. The highest clotlysis of the NSO and PHY was seen by 57.83 ± 0.23% and 53.05 ± 2.93% with 80 µL and 150 µg per tube, respectively. NSO co-treated with PHY showed a better clotlysis capacity than the NSO and PHY. The vehicle showed negligible clotlysis (2.86 ± 4.33%) capacity, while the standard SK (100 I.U.) showed 78.96 ± 1.08% clotlysis activity.Conclusion: NSO and/or PHY exhibited clotlysis activity in human clotted blood in in vitro.

Keywords: Nigella sativa oil; Phytol; Antioxidant; Atherothrombosis; Cardiovascular; diseases

The full text of this article is available as a PDF. Open the PDF.